Drug susceptibility of isolates from severe postoperative intraperitoneal infections causing multiple organ failure

被引:3
作者
Kusachi, S [1 ]
Sumiyama, Y [1 ]
Nagao, J [1 ]
Arima, Y [1 ]
Yoshida, Y [1 ]
Tanaka, H [1 ]
Nakamura, Y [1 ]
Saida, Y [1 ]
Watanabe, M [1 ]
Sato, J [1 ]
机构
[1] Toho Univ, Sch Med, Dept Surg 3, Meguro Ku, Tokyo 1538515, Japan
关键词
postoperative infection; severe intraperitoneal infection; methicillin-resistant Staphylococcus aureus; imipenem;
D O I
10.1007/s00595-004-2910-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. To select the most appropriate antibiotic regimens for life-threatening postoperative infections, we obtained isolates from patients with severe postoperative infections over a 12-year-period, and examined their drug susceptibility. Methods. The subjects of this study were 55 patients with multiple organ failure (MOF) caused by postoperative infection. Results. All strains of Methicillin-resistant Staphylococcus aureus (MRSA) were susceptible to Vancomycin (VCM) and Teicoplanin (TEIC). Only 0.3% of all the Pseudomonas aeruginosa strains were resistant to Imipenem (IPM), but 53.6% of the strains from the severe infections were resistant to IPM. On the other hand, there were few P. aeruginosa strains resistant to Meropenem (MEPM), Ceftazidime (CAZ), Ciprofloxacin (CPFX), and Pazufloxacin (PZFX), even among strains isolated from severe infections. The resistant rate of Bacteroides fragilis to Clindamycin (CLDM) was 35.9%, but there were strains resistant to IPM and Panipenem. Conclusion. These findings suggest that VCM or TEIC are most appropriate for severe abdominal abscess caused by MRSA, whereas MEPM, CAZ, CPFX, and PZFX are more effective against P. aeruginosa infections. The only antibiotic effective against B. fragilis infections in this study was IPM.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 17 条
[1]   Bacteremia due to Bacteroides fragilis group:: distribution of species, β-lactamase production, and antimicrobial susceptibility patterns [J].
Aldridge, KE ;
Ashcraft, D ;
O'Brien, M ;
Sanders, CV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :148-153
[2]   OUTER-MEMBRANE PERMEABILITY IN PSEUDOMONAS-AERUGINOSA - COMPARISON OF A WILD-TYPE WITH AN ANTIBIOTIC-SUPERSUSCEPTIBLE MUTANT [J].
ANGUS, BL ;
CAREY, AM ;
CARON, DA ;
KROPINSKI, AMB ;
HANCOCK, REW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) :299-309
[3]  
ASAHI Y, 1985, CHEMOTHERAPY TOKY S4, V33, P54
[4]   Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group [J].
Falagas, ME ;
McDermott, L ;
Snydman, DR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2047-2049
[5]  
FRUIT AC, 2001, EUR J CLIN MICROBIOL, V20, P617
[6]   Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe [J].
Hedberg, M ;
Nord, CE .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) :475-488
[7]   Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa [J].
Higgins, PG ;
Fluit, AC ;
Milatovic, D ;
Verhoef, J ;
Schmitz, FJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) :299-300
[8]   Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000):: More alike than different! [J].
Jones, RN ;
Beach, ML ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (03) :161-163
[9]   ANTIBACTERIAL ACTIVITY OF MEROPENEM AGAINST GRAM-NEGATIVE BACTERIA WITH A PERMEABILITY DEFECT AND AGAINST STAPHYLOCOCCI [J].
KITZIS, MD ;
ACAR, JF ;
GUTMANN, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 :125-132
[10]   New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection [J].
Kusachi, S ;
Sumiyama, Y ;
Nagao, J ;
Kawai, K ;
Arima, Y ;
Yoshida, Y ;
Kajiwara, H ;
Saida, Y ;
Nakamura, Y .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1999, 29 (08) :724-729